Skip to main content
Ono Pharmaceutical Co., Ltd. (TYO:4528)
Japan flag Japan · Delayed Price · Currency is JPY
2,477.50
-43.50 (-1.73%)
At close: Mar 9, 2026

Ono Pharmaceutical Revenue

Ono Pharmaceutical had revenue of 139.90B JPY in the quarter ending December 31, 2025, with 4.23% growth. This brings the company's revenue in the last twelve months to 509.35B, up 4.52% year-over-year. In the fiscal year ending March 31, 2025, Ono Pharmaceutical had annual revenue of 486.87B, down -3.14%.

Revenue (ttm)
509.35B
Revenue Growth
+4.52%
P/S Ratio
2.29
Revenue / Employee
118.81M
Employees
4,287
Market Cap
1,164.20B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2025486.87B-15.80B-3.14%
Mar 31, 2024502.67B55.49B12.41%
Mar 31, 2023447.19B85.83B23.75%
Mar 31, 2022361.36B52.08B16.84%
Mar 31, 2021309.28B16.86B5.77%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Kyowa Kirin 496.83B
Santen Pharmaceutical 287.99B
Astellas Pharma 2,060.61B
Daiichi Sankyo Company 2,052.15B
Otsuka Holdings 2,468.89B
Chugai Pharmaceutical 1,257.94B
JCR Pharmaceuticals 37.55B
Perseus Proteomics 140.41M
Revenue Rankings

Ono Pharmaceutical News

More News